Patent · US Active

Intermittent monitoring

US11998322B2 · kind B2 · utility

3Cited by
8References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2019
Grant dateJun 4, 2024
Priority date
Expiry dateDec 17, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16H20/17
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Various examples are directed to systems and methods for patient monitoring. An example method comprises receiving an estimated glucose concentration level of the patient from a continuous glucose monitoring (CGM) system for a first time period. The method may also include receiving non-glucose information relating to the patient for the first time period and determining a relationship between the estimated glucose concentration level and the non-glucose information. The method may also include receiving non-glucose information relating to the patient for a second time period and determining diabetic information about the patient for the second time period based upon the determined relationship and the non-glucose information. The method may include electronically delivering a notification about the diabetic information.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.